Trade Spotlight | What should you do with PVR, BLS International Services, RPG Life Sciences on Thursday?
RPG Life Sciences was another stock that we selected for trade spotlight, rising 4 percent to end at record closing high of Rs 855.80. It has seen high wave kind of pattern formation on the daily charts, and bullish candle for fifth consecutive month.
Hot Stocks | RPG Life, Krishna Institute of Medical Sciences, Pfizer can give healthy returns in short term. Here's why
Indicators and oscillators like MACD (moving average convergence and divergence) and RSI have turned bullish on the weekly charts. KIMS is placed above all important moving averages, indicating bullish trend on all time frames.
Hot Stocks | RPG Life Sciences, Poonawalla Fincorp, Welspun can deliver over 10% return in short term. Here's why
RPG Life Sciences has broken out from the Bullish Flag pattern on the daily chart. Stock has been forming higher tops and higher bottoms on the daily charts. Recently the stock price registered fresh all-time high at Rs 804 and current levels are very near to that level.
#RPGLIFE : Sudden uptrend started today in RPGLIFE for short term. CMP 601.05. its at upper circuit today. keep watching for next few days (Its my personal view, do your analysis or consult with your adviser before you trade)
Ahead of Market: 12 things that will decide stock action on Friday
Chandan Taparia of Motilal Oswal Securities said, Nifty needs to decisively hold above 14,400 level to witness a bounce towards 14,600 and 14,700 levels, while on the downside, support exists at 14,250 and 14,150 levels.
Concerned about Covid wave, but better prepared than last year: Companies
Companies have arranged accommodation for workers at factory and work sites and are offering them counselling, to avoid mass exodus of migrant workers as seen during the lockdown last year. They are pushing vaccination among employees.
RPG Life Sciences shifts gears, bets on chronic drugs to expand sales, profits
The drugmaker wants the chronic segment to account for 50 percent of revenue. Currently, RPG Life Sciences’ business mix is heavily skewed towards acute drugs, with over two-thirds of sales coming from this segment